The intergovernmental Nuclear Energy Agency (NEA) has called for fundamental changes in government policy and cooperation with industry to reform what the agency identified as an “unsustainable economic structure” for the supply of isotopes for nuclear medicine.
Hendricks Holdings has invested in NorthStar Medical Radioisotopes, which will allow the company to introduce new technologies and production methodologies for molybdenum-99 and other radioisotopes.
The FDA has approved Covidien’s production of technetium-99m (Tc-99m) derived from the low-enriched uranium molybdenum-99 (Mo-99) isotope.
RSS 
